3 edition of AXYS PHARMACEUTICALS, INC. found in the catalog.
AXYS PHARMACEUTICALS, INC.
ICON Group Ltd.
April 25, 2000
by Icon Group International
Written in English
|The Physical Object|
|Number of Pages||21|
Visium Technologies, Inc. was incorporated in Nevada as Jaguar Investments, Inc. during October During March , a wholly owned subsidiary of the Company merged with Freight Rate, Inc., a development stage company in the logistics software business. During May , the Company changed its name to Power2Ship, Inc. Corvus Pharmaceuticals, Inc. Mitten Road, Suite Burlingame, CA Telephone: () Bruce K. Dallas, Esq. Davis Polk & Wardwell LLP El Camino Real Menlo Park, CA Telephone: () Facsimile: ()
Axys Pharmaceuticals, Inc. (fka Sequana Therapeutics, last known as Celera Therapeutics), La Jolla, CA Responsibilities included designing electromechanical hardware, software (custom schedulers) and graphical user interfaces for integrating the automation and implementing protocols, along with conducting research into new technologies that. Note: Although this list can be sorted by the amount of funding each organization receives, these data should not be interpreted as a ranking of institutions by NIH. NIH's use of multiple principal investigator awards makes calculations of the total funding received by individual departments impractical and there are multiple ways in which the funding data can be aggregated across .
Speaker Bios. Jerry L. Adams, Ph.D., Director, Medicinal Chemistry, Immuno-Oncology & Combinations DPU, GlaxoSmithKline Pharmaceuticals. Jerry earned a doctorate in Chemistry (UC Berkeley, ). He worked initially on transition-state analog and suicide enzyme inhibitors. In , his group discovered the first selective inhibitors of p38α. LabRoots and the Genetics and Genomics planning committee are excited to announce they will be hosting the 7th Annual Genetics and Genomics Virtual Event May , This distinguished, on.
Annie and Snowball and the prettiest house
Architecture of the Renaissance in England
Medical ethics in India.
Womens health USA 2002
Plans and instructions for Volkswagen van camper
On a clear day they could see seventh place
Thysanura and Diptura
Labor management safety committees
Treasury of Snake Lore
manual for baby-sitters
The secrets of the famous Lazarus Riverius, councellor & physician to the French king, and professor of physick in the University of Montpelier
SEQUUS PHARMACEUTICALS, INC.: International Competitive Benchmarks and Financial Gap Analysis (Financial Performance Series) [Ltd., Icon Group] on *FREE* shipping on qualifying offers.
SEQUUS PHARMACEUTICALS, INC.: International Competitive Benchmarks and Financial Gap Analysis (Financial INC. book Series)Author: Icon Group Ltd. UNIMED PHARMACEUTICALS, INC.: Labor Productivity Benchmarks and International Gap Analysis (Labor Productivity Series) [Ltd., Icon Group] on *FREE* shipping on qualifying offers.
UNIMED PHARMACEUTICALS, INC.: Labor Productivity Benchmarks and International Gap Analysis (Labor Productivity Series)Author: Icon Group Ltd. Axys Pharmaceuticals announces staff addition. South San Francisco-based Axys Pharmaceuticals Inc.
today named Michael John Green vice president of medicinal chemistry, reporting to Michael C. Company: Axys Pharmaceuticals, Inc. SSF USD 11/30/ Page 2 IN SERVICE CURRENT PERIOD YEAR TO DATE LIFE TO DATE DATE CONV LIFE REM LIFE METHOD BASIS BOOK VALUE DEPRECIATION DEPRECIATION DEPRECIATION Asset: Tag: A Asset Grp: COMBI99 Lab Eq Freezemobile 25 EL Cat: D Sim: N Tax.
Hastings was recently the Chairman and CEO of OncoMed Pharmaceuticals. Prior to joining OncoMed inMr. Hastings was President and Chief Executive Officer of QLT, Inc. Previous to that, Mr. Hastings served as President and Chief Executive Officer of Axys Pharmaceuticals, which was acquired by Celera Corporation in Paul Hastings is Chief Executive Officer of Nkarta Therapeutics, Inc.
and formerly served as President, Chief Executive Officer, a member of the Board of Directors, and Chairman of the Board of OncoMed Pharmaceuticals from through January 1, Mr. Hastings was previously President and Chief Executive Officer of QLT,Inc. Prior to Theravance, Dr.
Jenkins led a discovery team at Axys Pharmaceuticals, Inc., where he discovered a novel mechanism for the inhibition of serine proteases that led to several multi-million dollar strategic collaborations.
From toMr. Hastings served as President and Chief Executive Officer of Axys Pharmaceuticals, Inc., which was acquired by Celera Corporation in The merged company became Axys Pharmaceuticals Inc., which Alameda-based Celera bought in for $ million.
Celera’s royalty interest has flown under the radar, BioWorld Today notes Author: Ron Leuty. Lesley Stolz, PhD, fosters Johnson & Johnson’s external R&D engine and supports the innovation community by leading the Johnson & Johnson Innovation, JLABS business on the West Coast.
She has 20 years of business and corporate development experience working for companies that have been both technology platform and therapeutics focused. South San Francisco-based Arris Pharmaceutical Corp. said yesterday it will buy San Diego-based Sequana Therapeutics Inc. and create a new.
ONCOMED PHARMACEUTICALS, INC. Hastings served as President and Chief Executive Officer of Axys Pharmaceuticals, Inc., which was acquired by Celera Corporation in Lewicki has.
NIH Proteomics Grant to Axys. Axys Pharmaceuticals Inc. of South San Francisco, California, has been awarded a Phase I Small Business Innovation Research grant from the NIH National Institute of General Medical Sciences to conduct a 6-month research study of proteomics.
Paul Hastings was appointed Chief Executive Officer of Nkarta in February Mr. Hastings was recently the Chairman and CEO of OncoMed Pharmaceuticals. Prior to joining OncoMed inMr.
Hastings was President and Chief Executive Officer of QLT, Inc. Previous to that, Mr. Hastings served as President and Chief Executive Officer of Axys Pharmaceuticals, which.
Biography and booking information for Paul Hastings, Chairman and Chief Executive Officer, OncoMed Pharmaceuticals. Contact All American Speakers Bureau to inquire about speaking fees and availability, and book the best keynote speaker for your next event.
Barry A. Bunin, Ph.D. is the CEO of Collaborative Drug Discovery. Bunin has overseen over $30 million in business transactions. Prior to CDD, Dr. Bunin was an Entrepreneur in Residence with Eli Lilly & Co. Bunin is on a patent for Kyprolis™ (Carfilzomib for Injection) — a selective proteasome inhibitor that received accelerated FDA approval for the treatment of patients with.
Celera Genomics, a Rockville company known for mapping the human genome, announced it would acquire AXYS Pharmaceuticals Inc., an integrated small molecule drug discovery and development company. The deal was structured as a stock swap in which AXYS shareholders would receive Celera share for each AXYS share.
David Gibson, X-Ray Optical Systems, Inc: Industry Perspectives II Richard Ramseyer, Honeywell Technology Center: Discussants: William Newall, Axys Pharmaceuticals, Inc Jeff Grove, House Committee on Science: Discussion: Panel III: Research Perspectives on the ATP Moderator: Richard Nelson, Columbia University: Assessment of.
The Chronicle / Company Profiles A-C Computer Networking Systems Employees: 13,; Bay Area: 3, 3Dfx Interactive Inc. Employees: ; Bay Area: 3DO Co. Redwood City, CA National Academy of Sciences. National Academy of Engineering.
Institute of Medicine. National Research Council. The National Academy of Sciences is a private, nonprofit, self-perpetuating society of distinguished scholars engaged in scientific and engineering research, dedicated to the furtherance of science and technology and to their use for the general welfare.
1 This filing is made pursuant to Rule (b)(4) under the Securities Act of in connection with Registration No. PROSPECTUS 5, Shares [DISCOVERY PARTNERS LOGO] Common Stock This is an initial public offering of common stock by Discovery Partners International, Inc.From toMr.
Hastings served as President and Chief Executive Officer of Axys Pharmaceuticals, Inc., which was acquired by Celera Corporation in From toMr. Hastings served as the President of Chiron BioPharmaceuticals, a division of .Secured Promissory Note and Agreement - Axys Pharmaceuticals Inc.
PE Corp. (NY) ( ) Promissory Note - Siden Investments Ltd. and Inc. ( ) Promissory Note - Identix Inc. and Erik E. Prusch (Oct 5, ) Promissory Note - Brookhaven Homes LP and Bismark Mortgage Co. LLC (Oct 3, ).